2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
56
NET
5
Endocrine
5
Thoracic
3
Head & Neck
3
Sarcoma
2
Gynecologic
2
Other neoplasm
1
Other
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Melanoma
3141
Skin Neoplasms
554
Lymphoma, T-Cell, Cutaneous
543
Carcinoma, Non-Small-Cell Lung
421
Neoplasms
388
Mycosis Fungoides
369
Breast Neoplasms
364
Carcinoma, Basal Cell
360
Keratosis, Actinic
335
Sezary Syndrome
331
Lymphoma, Non-Hodgkin
312
Carcinoma, Renal Cell
308
Neoplasm Metastasis
304
Lymphoma
300
Leukemia, Lymphocytic, Chronic, B-Cell
292
Lymphoma, Large B-Cell, Diffuse
287
Lymphoma, Follicular
286
Hodgkin Disease
275
Uveal Melanoma
274
Lymphoma, B-Cell, Marginal Zone
273
Lymphoma, Mantle-Cell
272
Precursor Cell Lymphoblastic Leukemia-Lymphoma
271
Burkitt Lymphoma
258
Lymphoma, Large-Cell, Immunoblastic
248
Lung Neoplasms
236
Colorectal Neoplasms
232
Ovarian Neoplasms
214
Lymphoma, Large-Cell, Anaplastic
206
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
203
Multiple Myeloma
199
Interventions
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Diseases
×
Dermatologic
×
Clear all
NCT04644315
2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2
Terminated
1 enrolled
5 charts